Just a Girl Lost 2

Just a girl lost~ Here I share bits & pieces of me, in poetry, prose, music & posts from writers who inspire me.


1 Comment

Dr. Michael Yeadon on Vaccine Passports: “We Will be Standing at the “Gates of Hell”

https://rumble.com/vfyt7p-dr.-michael-yeadon-on-vaccine-passports-we-will-be-standing-at-the-gates-of.html


Leave a comment

NHS Consultant of 30 years warns against vaccinating healthy children (Video Interview)

https://rumble.com/vh2ga7-nhs-consultant-of-30-years-warns-against-vaccinating-healthy-children.html


Leave a comment

VAERS BOMBSHELL: HHS Withholding 100s Of Thousands Of Reported Adverse Events: My Estimate is 750K+

If you want to be TERRIFIED, watch and share this: This is STUNNING.

MY GOD PEOPLE!
Multiple analysts are looking at the data & each are concluding the actual average deaths from these √4x5Hines may be 100-200k/mo!!!
FAR WORSE than anyone imagined.

https://odysee.com//embed/Vaersmissingbacklog-1/1dc7357e7d65fc5fba7ddc43a651b0f3da488c4d?


Leave a comment

Bombshell: Nobel Prize Winner Reveals – Covid Vaccine is ‘Creating Variants’ – RAIR

https://rairfoundation.com/bombshell-nobel-prize-winner-reveals-covid-vaccine-is-creating-variants/


Leave a comment

Moderna COVID-19 vaccine, mRNA 1273

*Excerpts from article are below.

Controversies

In May 2020, after releasing partial and non-peer reviewed results for only eight of 45 candidates in a preliminary pre-Phase I stage human trial directly to financial markets, the CEO announced on CNBC an immediate $1.25 billion rights issue to raise funds for the company, at a $30 billion valuation,[109] while Stat said, “Vaccine experts say Moderna didn’t produce data critical to assessing COVID-19 vaccine.”[110]

On 7 July, disputes between Moderna and government scientists over the company’s unwillingness to share data from the clinical trials were revealed.[111]

Moderna also faced criticism for failing to recruit people of color in clinical trials.[112]

Patent litigation

The PEGylated lipid nanoparticle (LNP) drug delivery system of mRNA-1273 has been the subject of ongoing patent litigation with Arbutus Biopharma, from whom Moderna had previously licensed LNP technology.[25][113] On 4 September 2020, Nature Biotechnology reported that Moderna had lost a key challenge in the ongoing case.[114]

https://wp.me/p38LX5-65x